Når ritonavir bruges i kombination med en anden protease - hæmmer og buprenorphin, skal produktresuméet for den protease - hæmmer, som administreres samtidigt, ses igennem for specifik information om dosering.
When ritonavir is used in combination with another protease inhibitor and buprenorphine, the SPC of the co-administered protease inhibitor should be reviewed for specific dosing information.